Lynx1 Capital Management LP
Top Portfolio Positions
22 positions ·
$632,594,991 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
4,763,673 | $155,105,192 | 24.52% |
| GHRS |
GH Research PLC
Healthcare
|
10,763,288 | $151,331,829 | 23.92% |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
8,963,500 | $127,371,335 | 20.13% |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
2,611,568 | $88,349,345 | 13.97% |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
1,880,303 | $36,101,817 | 5.71% |
| CCCC |
C4 Therapeutics, Inc.
Healthcare
|
6,998,902 | $18,407,112 | 2.91% |
| KRRO |
Korro Bio, Inc.
Healthcare
|
1,538,296 | $17,413,510 | 2.75% |
| TCRX |
TScan Therapeutics, Inc.
Healthcare
|
8,019,148 | $8,099,339 | 1.28% |
| XNCR |
Xencor Inc
Healthcare
|
536,398 | $6,468,959 | 1.02% |
| DTIL |
Precision Biosciences Inc
Healthcare
|
985,113 | $5,418,121 | 0.86% |
Holdings in DNLI
Export CSV
1 of 1 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,101,817 | 1,880,303 | Shares | Other | 2026-05-04 | |
| No quarters match your search. | ||||||